Metrikler
Yayın
194
Açık Erişim
52
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1994 - 1997
1994 - 1997Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Sağlık Bilimleri
Akademik Ünvanlar / Görevler
2004 - Devam Ediyor
2004 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (Türkçe), Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
1994 - Devam Ediyor
1994 - Devam EdiyorÖğretim Üyesi
Hacettepe Üniversitesi Tıp Fakültesi, Öğretim Üyesi
Makaleler
Tümü (106)
SCI-E, SSCI, AHCI (101)
SCI-E, SSCI, AHCI, ESCI (104)
ESCI (2)
Scopus (102)
TRDizin (26)
2024
20241. Transcriptome Analysis of Beta-Catenin-Related Genes in CD34+ Haematopoietic Stem and Progenitor Cells from Patients with AML
Gunes B. A., Ozkan T., Gurel A. K., Dalkilic S., Belder N., Ozkeserli Z., et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, cilt.16, sa.1, 2024 (SCI-Expanded, Scopus)
2024
20242. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations
ÜMİT E. G., DEMİR A. M., AR M. C., Ayer M., Ayli M., Karakus V., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.41, sa.3, ss.141-145, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
20243. The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: A single-center experience
Alayvaz Aslan N., BÜYÜKAŞIK Y., SAYINALP N.
Journal of Experimental and Clinical Medicine (Turkey)
, cilt.41, sa.1, ss.125-131, 2024 (Scopus)
2024
20244. Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major
FEDAİ A. B., KARAKULAK U. N., Aladag E., SAYINALP N.
Cardiovascular Toxicology
, cilt.24, sa.1, ss.41-48, 2024 (SCI-Expanded, Scopus)
2024
20245. Management of Adult Primary Immune Thrombocytopenia: DelphiBased Consensus Recommendations
DEMİR A. M., ÜMİT E. G., AR M. C., Ayer M., Ayli M., Karakus V., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.41, sa.2, ss.97-104, 2024 (SCI-Expanded, Scopus, TRDizin)
2024
20246. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients
MEHTAP Ö., TOPTAŞ T., Dal M. S., KEKLİK KARADAĞ F., Atas U., ÖZSAN G. H., et al.
LEUKEMIA & LYMPHOMA
, cilt.65, ss.2190-2198, 2024 (SCI-Expanded, Scopus)
2023
20237. History Of The Hematology Proficiency Exam And The Turkish Experience
BULDUK T., Demir A. M., Andic N., Sayınalp N., aylı m.
STED/Sürekli Tıp Eğitimi Dergisi
, cilt.32, sa.4, ss.281-291, 2023 (TRDizin)
2023
20238. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives
AR M. C., El Fakih R., Gabbassova S., Alhuraiji A., Nasr F., Alsaeed A., et al.
Leukemia Research
, cilt.133, 2023 (SCI-Expanded, Scopus)
2023
20239. Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up
Oğuz S. H., OKAY M., FEDAİ A. B., ÜNAL Ş., GÜMRÜK F., SAYINALP N., et al.
Endocrinology Research and Practice
, cilt.27, sa.4, ss.205-212, 2023 (Scopus, TRDizin)
2023
202310. A single-center experience of haploidentical stem cell transplantation in hematological malignancies
MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
202211. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation
KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202212. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study
KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202213. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine
Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202114. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia
ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)
2021
202115. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202016. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.
Transfusion and Apheresis Science
, cilt.59, sa.5, 2020 (SCI-Expanded, Scopus)
2019
201917. Indications and outcomes of splenectomy for hematological disorders
Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE
, cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus)
2016
201618. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Chanan-Khan A., Cramer P., Demirkan F., Fraser G., Silva R. S., Grosicki S., et al.
LANCET ONCOLOGY
, cilt.17, sa.2, ss.200-211, 2016 (SCI-Expanded, Scopus)
2016
201619. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias
Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201520. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia
ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY
, cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)
2015
201521. Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes.
Bektas O., Uner A., Buyukasik Y., Uz B., Bozkurt S., Eliacik E., et al.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
, cilt.123, ss.445-51, 2015 (SCI-Expanded, Scopus)
2015
201522. The factors affecting early death after the initial therapy of acute myeloid leukemia
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)
2015
201523. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201524. Clinicopathological associations of acquired erythroblastopenia
GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)
2015
201525. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA
, cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)
2014
201426. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission
Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201427. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management
GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201428. Increased Soluble Selectins as a Reflection of Activated Platelets and Endothelium in Legg-Calve-Perthes Disease
Ismayilov V., Aksoy D. Y., SAYINALP N., Haznedarog I. C., AKSOY M. C.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
, cilt.36, sa.7, 2014 (SCI-Expanded, Scopus)
2014
201429. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201430. Clinical Perspectives About the Molecular Management of B-Lymphoproliferative Neoplasms
HAZNEDAROĞLU İ. C., SAYINALP N.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.1-3, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201431. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature
Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201332. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201333. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY
, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)
2013
201334. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201335. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis
Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)
2013
201336. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis
Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201337. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201238. Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement
Turker B., Uz B., Isik M., BEKTAŞ Ö., DEMİROĞLU H., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.29, sa.4, ss.413-419, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201239. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL
Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201240. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML
AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
201141. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
201142. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)
2011
201143. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
, cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)
2011
201144. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia
Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)
2010
201045. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
201046. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)
2010
201047. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations
HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201048. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients
Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE
, cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)
2010
201049. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML
BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201050. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)
2009
200951. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY
, cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)
2009
200952. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded, Scopus)
2009
200953. The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey
Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.29, sa.2, ss.388-394, 2009 (SCI-Expanded, Scopus)
2009
200954. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded, Scopus)
2008
200855. Thrombomodulin and GFC levels in Legg-Calve-Perthes disease
AKSOY M. C., Aksoy D. Y., HAZNEDAROĞLU İ. C., Sayinalp N., Kirazli S., Alpaslan M.
HEMATOLOGY
, cilt.13, sa.6, ss.324-328, 2008 (SCI-Expanded, Scopus)
2008
200856. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma
Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY
, cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)
2008
200857. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients
BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded, Scopus)
2008
200858. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts
Koca E., BÜYÜKAŞIK Y., Cetiner D., Yimaz R., Sayinalp N., Yasavul U., et al.
LEUKEMIA RESEARCH
, cilt.32, sa.3, ss.495-499, 2008 (SCI-Expanded, Scopus)
2008
200859. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)
2007
200760. Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease
Koca E., Haznedaroglu I. C., ÜNER A., Sayinalp N., Saglam A. E., Goker H., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.99, sa.11, ss.1243-1246, 2007 (SCI-Expanded, Scopus)
2007
200761. Renin-angiotensin system expression in the K562 human erythroleukaemic cell line
Koca E., Haznedaroglu I. C., Acar K., Beyazit Y., Aksu S., Misirlioglu M., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.8, sa.3, ss.145-147, 2007 (SCI-Expanded, Scopus)
2007
200762. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia
Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.82, sa.4, ss.333, 2007 (SCI-Expanded, Scopus)
2007
200763. Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: Implications in the fibrinolytic process
Uckan D., Kirazli S., Gur D., Tavil B., Sayinalp N., Akyuz C.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
, cilt.39, sa.4, ss.376-379, 2007 (SCI-Expanded, Scopus)
2007
200764. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia
Beyazit Y., Aksu S., Haznedaroglu I. C., Kekilli M., Misirlioglu M., Tuncer S., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.99, sa.1, ss.57-63, 2007 (SCI-Expanded, Scopus)
2006
200665. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML
Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.
LEUKEMIA & LYMPHOMA
, cilt.47, sa.5, ss.891-896, 2006 (SCI-Expanded, Scopus)
2006
200666. Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation
Aksu S., Beyazit Y., Haznedaroglu I., Goker H., Kekilli M., Karakaya J., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.17, sa.1, ss.47-51, 2006 (SCI-Expanded, Scopus)
2005
200567. Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia Rubra vera
Aksu S., Beyazit Y., Hazneidaroglu I., Kekilli M., Canpinar H., Misirlioglu M., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.33, sa.6, ss.661-667, 2005 (SCI-Expanded, Scopus)
2005
200568. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease
Cemalettin M., Aksoy D., Haznedaroglu I., Sayinalp N., Kirazli S., Alpaslan M.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, cilt.22, sa.5, ss.391-399, 2005 (SCI-Expanded, Scopus)
2005
200569. Local umbilical cord blood renin-angiotensin system
Goker H., Haznedaroglu I., Beyazit Y., Aksu S., Tuncer S., Misirlioglu M., et al.
ANNALS OF HEMATOLOGY
, cilt.84, sa.5, ss.277-281, 2005 (SCI-Expanded, Scopus)
2005
200570. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia
GÖNEN C., Haznedaroglu I., Aksu S., Koca E., Goker H., Buyukasik Y., et al.
PLATELETS
, cilt.16, sa.1, ss.31-37, 2005 (SCI-Expanded, Scopus)
2004
200471. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders
Sayinalp N., Cinar H., ÜNER A., Haznedaroglu I., Buyukasik Y., Goker H., et al.
CLINICAL AND LABORATORY HAEMATOLOGY
, cilt.26, sa.4, ss.265-268, 2004 (SCI-Expanded, Scopus)
2004
200472. The predictability of factor V Leiden (FV : Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance
Sayinalp N., Haznedaroglu I., Aksu S., Buyukasik Y., Goker H., Parlak H., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.10, sa.3, ss.265-270, 2004 (SCI-Expanded, Scopus)
2004
200473. Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura
Sayinalp N., Haznedaroglu I., Buyukasik Y., Goker H., Aksu S., Kocoglu H., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.32, sa.1, ss.62-65, 2004 (SCI-Expanded, Scopus)
2002
200274. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease
Buyukasik Y., Karakus S., Goker H., Haznedaroglu I., Ozatli D., Sayinalp N., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.13, sa.4, ss.349-353, 2002 (SCI-Expanded, Scopus)
2002
200275. Bone marrow and peripheral blood c-kit ligand concentrations in patients with thrombocytosis and thrombocytopenia
Asik M., Haznedaroglu I., Karakus S., Aksu S., Kocoglu H., Buyukasik Y., et al.
EXPERIMENTAL HEMATOLOGY
, cilt.30, sa.6, ss.102, 2002 (SCI-Expanded, Scopus)
2002
200276. Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS)
Koklu S., Ertugrul D., Onat A., Karakus S., Haznedaroglu I., Buyukasik Y., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.69, sa.3, ss.210-213, 2002 (SCI-Expanded, Scopus)
2002
200277. Plasma thrombospondin in immune thrombocytopenic purpura
Ozcebe O., Karakus S., Haznedaroglu I., Goker H., Kosar A., Kocoglu H., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.30, sa.1, ss.52-55, 2002 (SCI-Expanded, Scopus)
2002
200278. Plasma thrombopoietin in patients with cavernous transformation of the portal vein
Goker H., Egesel T., Karakus S., Haznedaroglu I., Apras S., Buyukasik Y., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.75, sa.1, ss.91-94, 2002 (SCI-Expanded, Scopus)
2002
200279. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet's disease: evidence of a prethrombotic state
Ozatli D., Sayinalp N., Buyukasik Y., Karakus S., Haznedaroglu I., Kirazli S., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.21, sa.4, ss.137-140, 2002 (SCI-Expanded, Scopus)
2001
200180. Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis
Gurgey A., Haznedaroglu I., Egesel T., Buyukasik Y., Ozcebe O., Sayinalp N., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.67, sa.2, ss.107-111, 2001 (SCI-Expanded, Scopus)
2000
200081. The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis
Birdane A., Haznedaroglu I., Ozath D., Sayinalp N., Kosar A., Buyukasik Y., et al.
EXPERIMENTAL HEMATOLOGY
, cilt.28, sa.7, ss.120, 2000 (SCI-Expanded, Scopus)
2000
200082. Beta-thalassemia intermedia associated with homozygosity for the -87 (C-->T) mutation in a Turkish family.
Gumruk F., Mergen H., Oner R., Ozcebe O., Sayinalp N., Oner C., et al.
Hemoglobin
, cilt.24, sa.1, ss.23-9, 2000 (SCI-Expanded, Scopus)
1999
199983. Lumiaggregometry can be used for estimation of platelet functions in patients with thrombocytopenia.
Buyukasik Y., Ozatli D., Sayinalp N., Haznedaroglu I., Kirazli S., Ozcebe O., et al.
BLOOD
, cilt.94, sa.10, 1999 (SCI-Expanded, Scopus)
1999
199984. Reduced platelet volume in microalbuminuric diabetic patients.
Sayinalp S., Sayinalp N.
BLOOD
, cilt.94, sa.10, 1999 (SCI-Expanded, Scopus)
1999
199985. Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus
Ileri N., Buyukasik Y., Karaahmetoglu S., Ozatli D., Sayinalp N., Ozcebe O., et al.
HAEMOSTASIS
, cilt.29, sa.6, ss.318-325, 1999 (SCI-Expanded, Scopus)
1999
199986. Thrombosis and hemorrhage in chronic myeloproliferative disorders.
Bas B., Koksal A., Ozatli D., Haznedaroglu I., Buyukasik Y., Kosar A., et al.
BLOOD
, cilt.94, sa.10, 1999 (SCI-Expanded, Scopus)
1999
199987. Effects of interferon-alpha 2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha 2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease
Kosar A., Haznedaroglu S., Karaaslan Y., Buyukasik Y., Haznedaroglu I., Ozath D., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.19, ss.11-14, 1999 (SCI-Expanded, Scopus)
1999
199988. Risk factors in central retinal vein occlusion and activated protein C resistance
Guven D., Sayinalp N., Kalayci D., Dundar S., Hasiripi H.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
, cilt.9, sa.1, ss.43-48, 1999 (SCI-Expanded, Scopus)
1999
199989. Paget-Schroetter syndrome associated with FV:Q506 and prothrombin 20210A - A case report
Sayinalp N., Ozcebe O., Kirazli S., Dogan R., Dundar S., Gurgey A.
Angiology
, cilt.50, sa.8, ss.689-692, 1999 (SCI-Expanded, Scopus)
1998
199890. Paget-Schroetter syndrome in a patient with Factor V Leiden
Sayinalp N., Ozcebe O., Buyukasik Y., Kosar Y., Gurgey A., Dogan R., et al.
BRITISH JOURNAL OF HAEMATOLOGY
, cilt.102, sa.1, ss.252, 1998 (SCI-Expanded, Scopus)
1998
199891. Recombinant human erythropoietin increases platelet aggregation in chronic hemodialysis patients
Sayinalp N., Erdem Y., Ozcebe O., Buyukasik Y., Caglar S., Dundar S.
THROMBOSIS RESEARCH
, cilt.90, sa.4, ss.195-198, 1998 (SCI-Expanded, Scopus)
1998
199892. Perianal infections in patients with leukemia - Importance of the course of neutrophil count
Buyukasik Y., Ozcebe O., Sayinalp N., Haznedaroglu I., Altundag O., Ozdemir O., et al.
DISEASES OF THE COLON & RECTUM
, cilt.41, sa.1, ss.81-85, 1998 (SCI-Expanded, Scopus)
1997
199793. Penile gangrene in lung cancer - Bronchiolo-alveolar carcinoma, disseminated intravascular coagulation, and nonbacterial thrombotic endocarditis.
Buyukasik Y., Sayinalp N., Arici M., Haznedaroglu I., Ozcebe O., Dundar S.
POSTGRADUATE MEDICAL JOURNAL
, cilt.73, sa.863, ss.589-590, 1997 (SCI-Expanded, Scopus)
1997
199794. Neutropenic enterocolitis in adult leukemias
Buyukasik Y., Ozcebe O., Haznedaroglu I., Sayinalp N., Soylu A., Ozdemir O., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.66, sa.1, ss.47-55, 1997 (SCI-Expanded, Scopus)
1996
199695. Plasma fibrinogen and coagulation inhibitors in nondiabetic offspring of patients with NIDDM.
Sayinalp S., Bayraktar M., Sayinalp N., Ozdemir O., Ozcebe O., Haznedaroglu I., et al.
BLOOD
, cilt.88, sa.10, ss.3037, 1996 (SCI-Expanded, Scopus)
1996
199696. Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma
Ozdemir O., Emri S., Karakoca Y., Sayinalp N., Akay H., Dundar S., et al.
THROMBOSIS RESEARCH
, cilt.84, sa.2, ss.121-128, 1996 (SCI-Expanded, Scopus)
1996
199697. Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity
Gursoy M., Haznedaroglu I., Celik İ., Sayinalp N., Ozcebe O., Dundar S.
ANNALS OF PHARMACOTHERAPY
, cilt.30, ss.762-765, 1996 (SCI-Expanded, Scopus)
1996
199698. Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients
Haznedaroglu I., Erdem Y., Yalcin A., Sayinalp N., Yasavul U., Turgan C., et al.
NEPHRON
, cilt.73, sa.3, ss.486-487, 1996 (SCI-Expanded)
1996
199699. Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients
Haznedaroglu I., Erdem Y., Celik İ., Sayinalp N., Dundar S., Caglar S., et al.
BLOOD PURIFICATION
, cilt.14, sa.3, ss.227-233, 1996 (SCI-Expanded, Scopus)
1996
1996100. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease
Sayinalp S., Akalin S., Sayinalp N., Erbas T., Bayraktar M., Ozcebe O., et al.
HORMONE AND METABOLIC RESEARCH
, cilt.28, sa.3, ss.133-137, 1996 (SCI-Expanded, Scopus)
1996
1996101. Cytokines in Behçet's disease.
Sayinalp N., Ozcebe O. I., Ozdemir O., Haznedaroğlu I. C., Dündar S., Kirazli S.
The Journal of rheumatology
, cilt.23, ss.321-2, 1996 (SCI-Expanded, Scopus)
1996
1996102. Cytokines in Behcet's disease
Sayinalp N., Ozcebe O., Ozdemir O., Haznedaroglu I., Dundar S., Kirazli S.
JOURNAL OF RHEUMATOLOGY
, cilt.23, sa.2, ss.321-322, 1996 (SCI-Expanded, Scopus)
1996
1996103. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia
Haznedaroglu I., Ertenli I., Ozcebe O., Kiraz S., Ozdemir O., Sayinalp N., et al.
ACTA HAEMATOLOGICA
, cilt.95, sa.2, ss.107-111, 1996 (SCI-Expanded, Scopus)
1995
1995104. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis
Sayinalp N., Erdem Y., Haznedaroglu I., Dundar S., Caglar S., Kirazli S.
CLINICAL NEPHROLOGY
, cilt.44, sa.6, ss.404, 1995 (SCI-Expanded, Scopus)
1995
1995105. BLOOD COLLECTION IN STRONG ACIDIC CITRATE ANTICOAGULANT FOR THE DETERMINATION OF UROKINASE-LIKE PLASMINOGEN ACTIVATOR
OZDEMIR O., HAZNEDAROGLU I., SAYINALP N., OZCEBE O., DUNDAR S., KIRAZLI S.
THROMBOSIS RESEARCH
, cilt.80, sa.2, ss.189-191, 1995 (SCI-Expanded, Scopus)
1995
1995106. MEGAKARYOCYTOPOIETIC CYTOKINES IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA
HAZNEDAROGLU I., SAYINALP N., OZCEBE O., OZDEMIR O., DUNDAR S., KIRAZLI S.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.49, sa.3, ss.265, 1995 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2016
20161. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia
TÜRK S., GHASEMİ M., MALKAN Ü. Y., ERİKÇİ A., GÖKER H., SAYINALP N., et al.
41. FEBS Kongresi, Türkiye, 3 - 08 Eylül 2016, (Özet Bildiri)
2016
20162. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia
TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374, (Özet Bildiri)
2014
20143. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
Desteklenen Projeler
2020 - 2021
2020 - 2021
COVID-19 Hastalarında Anjiyotensin Dönüstürücü Enzim Gen Polimorfizmlerinin Klinik Sonlanımlara Etkisinin Araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAYINALP N. (Yürütücü), AKBABA T. H., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., İNKAYA A. Ç., PEYNİRCİOĞLU B.
2011 - 2020
2011 - 2020Myledisplastik Sendromda PUMA ve p53'ün prognostik Öneminin Değerlendirilmesi
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
SAYINALP N. (Yürütücü)